The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Does Mounjaro Cause Inflammation?
Inflammation is not listed as a common side effect of Mounjaro in UK clinical data, but understanding how GLP-1 and GIP receptor agonists affect your body is important. Mounjaro (tirzepatide) is a prescription-only injection approved in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with weight-related health conditions. This guide explains what the evidence shows about inflammation risk, how to access Mounjaro safely, and the difference between NHS and private prescription routes in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Does Clinical Evidence Show About Mounjaro and Inflammation?
In the SURMOUNT clinical trials, the most common side effects of Mounjaro were gastrointestinal rather than inflammatory in nature—nausea, diarrhoea, vomiting, and constipation affected many participants. Inflammation specifically was not reported as a frequent adverse effect. However, some patients report joint or muscle pain during tirzepatide treatment, which could be related to gradual weight management or underlying conditions rather than the medication directly causing inflammation.
One important consideration: if you have a history of pancreatitis, thyroid problems, or inflammatory bowel conditions, you must inform your GP or prescriber before starting Mounjaro. Pancreatitis (inflammation of the pancreas) is a serious but rare side effect that requires immediate medical attention—seek urgent care if you experience severe stomach pain spreading to your back. The medication works by activating GIP and GLP-1 pathways, which generally have anti-inflammatory properties in the body, but individual responses vary.
- Report any unusual joint pain, swelling, or redness to your GP
- Serious allergic reactions (facial swelling, difficulty breathing) require emergency care
- Monitor for signs of pancreatitis: severe upper abdominal pain, nausea, vomiting
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Accessing Mounjaro in the UK: NHS vs Private Routes and Cost Context
In the UK, Mounjaro is available through two routes: NHS specialist weight management services and private prescription. NHS access requires referral from your GP to a tier 3 or tier 4 specialist weight management service, though availability varies significantly by region and waiting lists can be lengthy. Private access involves an online consultation with a UK-licensed prescriber following clinical assessment—no NHS referral is needed, and the process is typically faster.
Private prescription costs vary by dose and provider but generally range from approximately £129 to £320 per month depending on your Mounjaro dose and supplier. The Mounjaro KwikPen contains 4 weeks of doses. Always check that any provider is registered with the GPhC (General Pharmaceutical Council). Before starting Mounjaro, use our free GLP-1 weight loss calculator to understand potential outcomes alongside your BMI—your prescriber will assess eligibility based on your individual health, weight, and any weight-related conditions like type 2 diabetes or hypertension.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is inflammation a common side effect of Mounjaro in the UK?
No, inflammation is not listed as a common side effect of Mounjaro in clinical trials or UK safety data. The most frequent side effects are gastrointestinal (nausea, diarrhoea, constipation). Some patients report joint or muscle pain, which may relate to gradual weight management or pre-existing conditions rather than the medication directly. Always report any new symptoms to your GP.
What is the difference between Mounjaro and Wegovy for inflammation risk?
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are GLP-1 based medications with similar side effect profiles. Mounjaro is a dual GIP/GLP-1 agonist, while Wegovy is GLP-1 only. Neither has inflammation as a primary reported adverse effect. Individual tolerance varies—your prescriber can help choose which is more suitable for you.
How much does Mounjaro cost privately in the UK?
Private Mounjaro prescription costs typically range from £129 to £320 per month depending on dose and provider. Starting doses (2.5 mg) are usually lower cost than maximum doses (15 mg). Each Mounjaro KwikPen contains 4 weekly doses. Always verify the provider is GPhC-registered before purchasing.
Can I get Mounjaro on the NHS in the UK?
Yes, Mounjaro is available through NHS specialist weight management services following NICE approval. Access requires GP referral to tier 3 or tier 4 services, but availability and waiting times vary significantly by region. Contact your GP to ask about specialist weight management services in your area.
What should I do if I experience joint pain or swelling while taking Mounjaro?
Report any new joint pain, swelling, or inflammation to your GP promptly. While these symptoms are not common with Mounjaro, they could indicate an underlying condition or response to gradual weight management. Your GP can assess whether the medication should continue or whether dose adjustment is needed. Do not stop taking Mounjaro without medical guidance.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.